A Study to Evaluate Time in Range in Type 2 Diabetics Using Afrezza® Plus Basal Insulin Compared to Multiple Daily Injections

Inclusion Criteria: 1. Age 18 years or older 2. Diagnosed with Type 2 diabetes mellitus treated with multiple daily injections 3. Screening A1c 7.5 % - 11.5% inclusive 4. Willing and able to wear CGM system during the study 5. Willing to use only inhaled insulin (Afrezza®) at meals and for correction 6. Able to understand, speak, read and write English 7. Female of child-bearing potential willing to use contraceptive measures to prevent pregnancy Exclusion Criteria: 1. Diagnosed with COPD 2. Is an active smoker , or has smoked in the past 6 months 3. Diagnosed with asthma 4. Pregnancy, breast-feeding or planning to become pregnant during study period 5. Have a disease or condition that, in the opinion of the Investigator, could affect subject safety or interfere with their participation in the study 6. Use of oral or injected corticosteroid within 6 weeks of study enrollment 7. Enrollment in another investigational trial at the time of screening